Studying a New Treatment for Type 2 Diabetes
There are more than 23 million people in the United States, including 1.6 million in New York State, who have type 2 diabetes, which occurs when the body is resistant to the action of insulin, a hormone produced by the pancreas to lower the blood sugar. Type 2 diabetes, which is often associated with obesity, can result in kidney failure, limb amputations, blindness, heart disease, and stroke when blood sugar levels are uncontrolled.
“Many of these individuals who are living with type 2 diabetes and obesity are trying tirelessly to manage their diabetes and blood sugar, but without success,” says Aida Saliby, MD, of the Department of Endocrinology at Beth Israel Medical Center. “They do not respond fully to diet and lifestyle modifications, or they become resistant to the effects of oral medications, requiring additional treatments to manage their disease. Given the severe and growing diabetes epidemic, there is a substantial need to develop new, more effective therapies,” she says.